| James F Moore, CRNA | |
|
100 W 4th St, Suite 310, Cookeville, TN 38501-2448 | |
| (931) 528-7877 | |
| (931) 526-3261 |
| Full Name | James F Moore |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 100 W 4th St, Cookeville, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073503801 | NPI | - | NPPES |
| 3602243 | Medicaid | TN | |
| 3050226 | Other | TN | BLUE CROSS BLUE SHIELD |
| 430035974 | Other | TN | MEDICARE RAILROAD |
| 74320946 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 8966 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James F Moore, CRNA 100 W 4th St, Suite 310, Cookeville, TN 38501-2448 Ph: (931) 528-7877 | James F Moore, CRNA 100 W 4th St, Suite 310, Cookeville, TN 38501-2448 Ph: (931) 528-7877 |
News Archive
A major impediment to treatment of substance use disorder (SUD) is a loss of behavioral flexibility, whereby one's judgment is impaired such that their actions continuously result in negative consequences.
Use of medical imaging during pregnancy increased significantly in the United States, a new study has found, with nearly a four-fold rise over the last two decades in the number of women undergoing computed tomography CT scans, which expose mothers and fetuses to radiation. Pregnant women are warned to minimize radiation exposure.
Axela Inc has introduced the dotLab Amine Reactive Sensor for stable covalent coupling of affinity reagents such as antibodies for use with the Axela dotLab System.
Heparin is widely used as an anticoagulant, but evokes in some patients a potentially life-threatening condition called HIT. Clinical scientists at Ludwig-Maximilians-Universitaet in Munich have now shown that inhibition of a single enzyme may markedly reduce this risk.
The U.S. Food and Drug Administration today approved Tecentriq (atezolizumab) to treat the most common type of bladder cancer, called urothelial carcinoma. This is the first product in its class (PD-1/PD-L1 inhibitors) approved to treat this type of cancer.
› Verified 7 days ago
Madelaine Pruitt, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Blvd, Cookeville, TN 38501 Phone: 601-826-2386 | |
Mr. Lawrence A Epps, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 W 4th St, Suite 310, Cookeville, TN 38501 Phone: 931-528-7877 Fax: 931-526-3261 | |
Michael Brandon Hardison, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 W 4th St, Suite 310, Cookeville, TN 38501 Phone: 931-528-7877 Fax: 931-526-3261 | |
Mr. Mark A Thomason, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 W 4th St, Suite 310, Cookeville, TN 38501 Phone: 931-528-7877 Fax: 931-526-3261 | |
Joseph Patrick Hall, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 W 4th St Ste 310, Cookeville, TN 38501 Phone: 931-528-7877 Fax: 931-526-3261 | |
Aaron A Jones, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 100 W 4th St Ste 100, Cookeville, TN 38501 Phone: 931-526-8115 Fax: 952-442-3620 |